Introduction | परिचय
Osimert 80 mg (Osimertinib) is a third-generation tyrosine kinase inhibitor (TKI) used in the treatment of non-small cell lung cancer (NSCLC) with EGFR T790M mutation. It is a widely prescribed medication for patients whose disease has progressed after first-line EGFR-TKI therapy.
Nepalma (नेपालमा), Osimert 80 mg केही विश्वसनय दुरी मानिने सफल नहीं खोज्ने रागी Onco Solution बाट खरिद किन्न सकिन्छन गर्न सकिन्छना सक्षमता गरिन्छित छ।
What is Osimert 80 mg? | Osimart 80 mg के हो?
Osimart 80 mg (ओसिमेर्टिनिब) is a targeted therapy that binds to EGFR mutations (T790M, L858R, and exon 19 deletion) to prevent the progression of NSCLC tumors. Manufactured by Everest Pharmaceuticals Ltd., it is effective in overcoming resistance seen in earlier EGFR-TKIs.
Osimart 80 mg (ओसिमार्ट 80 mg) मत्र मानावलि चिकित्सक थेरापी हो (टार्गेटेड थेरापी), जो क्षत्रिय रूपले कार्य गर्ने मान्व गर्छ गर्दछ।
Uses of Osimert 80 mg | Osimart 80 mg को प्रयोग
Osimart 80 mg is primarily used for:
- Metastatic NSCLC patients with EGFR T790M mutation.
- Patients whose disease has progressed after first-line EGFR-TKI therapy.
Dosage & Administration | मात्रा र प्रशासन
Recommended Dosage | सिफारिस गरियेको मात्रा
- Standard Dose: 80 mg once daily.
- With or without food.
- Continue until disease progression or unacceptable toxicity occurs.
Side Effects | चरित प्रभावित प्रतिक्रियाहरू।
Common side effects include:
- Interstitial Lung Disease (ILD) or Pneumonitis
- QTc Interval Prolongation
- Cardiomyopathy
- Keratitis
Where to Buy Osimert 80 mg in Nepal? | नेपालमा Osimart 80 mg कहाँ किन्ने?
If you are looking to buy Osimert 80 mg in Nepal, ensure you purchase it from a trusted supplier like Onco Solution.
Trusted Supplier in Nepal | परिचित आपूर्तिकर्ता
Onco Solution
- Website: www.oncosolution.com
- Supplier of Genuine Osimert 80 mg manufactured by Everest Pharmaceuticals Ltd.
- Offers secure and fast delivery across Nepal.
Conclusion | निष्कर्षान्तमक
Osimert 80 mg (Osimertinib) is an effective targeted therapy for EGFR T790M mutation-positive NSCLC patients. It provides better survival outcomes with fewer side effects than earlier-generation TKIs.
Nepalma Onco Solution (www.oncosolution.com) द्वारा के बिश्वसनीय मनीयाद्दा गर्ने सकिन्छन गर्ने सकिन्छना सक्षमता गर्न्होस्।
